SCHEMBL3072973

SCHEMBL3072973

OC(=S)N(Cc1ccccc1)Cc1ccccc1

nearest known ligand 0.65

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MGLL Q99685 3/20 0.65
ALDH1A1 P00352 4/20 0.57
GAA P10253 1/20 0.53
LMNA P02545 2/20 0.50
CA12 O43570 1/20 0.50
CA1 P00915 1/20 0.50
CA2 P00918 1/20 0.50
CA9 Q16790 1/20 0.50
RECQL P46063 1/20 0.49
NPSR1 Q6W5P4 3/20 0.48
TSHR P16473 2/20 0.48
GRIN2D O15399 1/20 0.47
GRIN3B O60391 1/20 0.47
GRIN1 Q05586 1/20 0.47
GRIN2A Q12879 1/20 0.47
GRIN2B Q13224 1/20 0.47
GRIN2C Q14957 1/20 0.47
GRIN3A Q8TCU5 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL817571 0.98 MGLL (0.63) MGLLALDH1A1GAALMNACA12
SCHEMBL319905 0.93 MGLL (0.59) MGLLALDH1A1GAALMNACA12
SCHEMBL9360060 0.91 MGLL (0.57) MGLLALDH1A1GAALMNACA12
SCHEMBL15158086 0.91 MGLL (0.57) MGLLALDH1A1GAALMNACA12
SCHEMBL28773652 0.91 MGLL (0.57) MGLLALDH1A1GAALMNACA12
SCHEMBL4023191 0.91 MGLL (0.57) MGLLALDH1A1GAALMNACA12
SCHEMBL9355787 0.91 MGLL (0.57) MGLLALDH1A1GAALMNACA12
Water SCHEMBL20657972 0.89 MGLL (0.55) MGLLALDH1A1GAALMNACA12
SCHEMBL11835849 0.85 MGLL (0.65) MGLLALDH1A1GAALMNACA12
Acetic Acid SCHEMBL28905857 0.83 LMNA (0.50) MGLLALDH1A1LMNACA12CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10092579-B2 Gold(I) complexes with anticancer properties and methods of use thereof KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) 2018-10-09 US disclosed
US-20170232012-A1 GOLD(I) COMPLEXES WITH ANTICANCER PROPERTIES AND METHODS OF USE THEREOF KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) 2017-08-17 US disclosed
US-20170197997-A1 GOLD(I) COMPLEXES WITH ANTICANCER PROPERTIES AND METHODS OF USE THEREOF KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) 2017-07-13 US disclosed
US-9573967-B2 N-heterocyclic carbene gold complexes with anticancer properties and methods of use thereof KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) 2017-02-21 US disclosed
US-20160326187-A1 N-HETEROCYCLIC CARBENE GOLD COMPLEXES WITH ANTICANCER PROPERTIES AND METHODS OF USE THEREOF KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) 2016-11-10 US disclosed
US-7833331-B2 Non-toxic corrosion-protection pigments based on cobalt UNIVERSITY OF DAYTON (US) 2010-11-16 US disclosed
US-7789958-B2 Non-toxic corrosion-protection pigments based on manganese UNIVERSITY OF DAYTON (US) 2010-09-07 US disclosed
US-20090163628-A1 NON-TOXIC CORROSION-PROTECTION PIGMENTS BASED ON COBALT STURGILL JEFFREY ALLEN 2009-06-25 US disclosed
US-7422793-B2 Non-toxic corrosion-protection rinses and seals based on rare earth elements UNIVERSITY OF DAYTON (US) 2008-09-09 US disclosed
US-7407711-B2 Non-toxic corrosion-protection conversion coats based on rare earth elements UNIVERSITY OF DAYTON (US) 2008-08-05 US disclosed
US-20040016910-A1 Non-toxic corrosion-protection rinses and seals based on rare earth elements DAYTON, UNIVERSITY OF 2004-01-29 US disclosed
US-20040011252-A1 Non-toxic corrosion-protection pigments based on manganese UNIVERSITY OF DAYTON 2004-01-22 US disclosed
US-20030234063-A1 Non-toxic corrosion-protection conversion coats based on cobalt DAYTON, UNIVERSITY OF 2003-12-25 US disclosed
US-20030230363-A1 Non-toxic corrosion-protection rinses and seals based on cobalt UNIVERSITY OF DAYTON 2003-12-18 US disclosed
WO-2003060192-A1 NON-TOXIC CORROSION-PROTECTION RINSES AND SEALS BASED ON COBALT UNIVERSITY OF DAYTON (US) 2003-07-24 WO disclosed
WO-2003060019-A1 NON-TOXIC CORROSION PROTECTION PIGMENTS BASED ON COBALT UNIVERSITY OF DAYTON (US) 2003-07-24 WO disclosed
US-5925708-A SILANOL, SODIUM HYDROXIDE AND BUTADIENE-STYRENE COPOLYMER DEGUSSA AKTIENGESELLSCHAFT (DE) 1999-07-20 US disclosed
EP-0873375-A1 USE OF A COMBINATION OF SILICONE COMPOUNDS AS A COUPLING AGENT IN SILICA-LOADED ELASTOMER COMPOSITIONS RHODIA CHIMIE (FR) 1998-10-28 EP disclosed
US-5717038-A CROSSLINKING RUBBER WITH 1,2-BIS(N,N-DIBENZYLTHIOCARBAMOYLDISULFIDO)ETHANE BAYER AKTIENGESELLSCHAFT (DE) 1998-02-10 US disclosed
WO-1997025374-A1 USE OF A COMBINATION OF SILICONE COMPOUNDS AS A COUPLING AGENT IN SILICA-LOADED ELASTOMER COMPOSITIONS RHODIA CHIMIE (FR) 1997-07-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10092579-B2 Gold(I) complexes with anticancer properties and methods of use thereof MCL1, BAD, TP53 MGLL 3350/4885ALDH1A1 1409/4885GAA 4088/4885
US-20170232012-A1 GOLD(I) COMPLEXES WITH ANTICANCER PROPERTIES AND METHODS OF USE THEREOF MCL1, BAD, TP53 MGLL 3350/4885ALDH1A1 1409/4885GAA 4088/4885
US-20160326187-A1 N-HETEROCYCLIC CARBENE GOLD COMPLEXES WITH ANTICANCER PROPERTIES AND METHODS OF USE THEREOF MCL1, HCCS, ACIN1 MGLL 3984/4885ALDH1A1 1094/4885GAA 4421/4885
US-20170197997-A1 GOLD(I) COMPLEXES WITH ANTICANCER PROPERTIES AND METHODS OF USE THEREOF MCL1, BAD, TP53 MGLL 3350/4885ALDH1A1 1409/4885GAA 4088/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.